Internet-delivered interventions for people with depression and anxiety in IAPT services

Not Applicable

Completed

• Conditions: Depression and anxiety disorders; Mental and Behavioural Disorders

• Registration Number: ISRCTN91967124
• Lead Sponsor: SilverCloud Health

Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29499675 protocol 2020 Results article in https://doi.org/10.1038/s41746-020-0293-8 results (added 01/09/2020) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33835414/ assessment of psychometric measures (added 14/07/2021) 2021 Preprint results in https://preprints.jmir.org/preprint/26221 non-peer-reviewed dropout results (added 14/07/2021) 2021 Results article in https://doi.org/10.1002/cpp.2619 nested longitudinal qualitative results (added 14/07/2021) 2021 Results article in https://doi.org/10.1007/s10608-020-10200-6 secondary analysis (added 14/07/2021) 2022 Results article in https://doi.org/10.1016/j.jval.2021.11.1358 Cost-Effectiveness (added 01/07/2022) 2022 Results article in https://doi.org/10.1002/cpp.2743 Durability of treatment effects (added 01/07/2022) 2022 Results article in https://doi.org/10.1002/jclp.23403 The relationship between posttherapeutic Cognitive Behavior Therapy skills usage and follow-up outcomes of internet-delivered Cognitive Behavior Therapy (added 01/07/2022) 2023 Other publications in https://pubmed.ncbi.nlm.nih.gov/37436812/ secondary analysis (added 14/08/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-06
• Study Completion: 2019-08-01
• Last Update Posted: 26 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 361

Inclusion Criteria

1. A score of = 9 on PHQ-9 and/ or a score of = 8 on GAD-7
2. 18 years of age
3. Suitable for an internet-delivered intervention (iCBT)
4. Users of the Berkshire NHS Trust IAPT Talking Therapies Step 2 services

Exclusion Criteria

1. Suicidal intent/ideation
2. Psychotic illness
3. Currently in psychological treatment for depression and/or anxiety
4. Alcohol or drug misuse
5. Previous diagnosis of an organic mental health disorder

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Depression is assessed using the Patient Health Questionnaire-9 (PHQ-9) at baseline, throughout treatment, at 8 weeks and at 3, 6, 9 and 12 months follow-up<br>2. Anxiety is assessed using the Generalized Anxiety Disorder-7 (GAD-7) at baseline, throughout treatment, at 8 weeks and at 3, 6, 9 and 12 months follow-up